Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.
Evolent Health reports developments tied to its healthcare services business for people with complex conditions. Company news commonly covers operating and financial results, customer activity with health plans and providers, and the Performance Suite contract model used in its specialty care operations.
Recurring updates also include Evolent's complex specialty care focus in oncology, cardiology and musculoskeletal conditions, management participation in healthcare investor conferences, leadership appointments, board and compensation matters, and equity-award disclosures under NYSE rules.
Evolent Health, Inc. (NYSE: EVH) reported Q1 2022 revenues of $297.1 million, up 38.1% YoY, with net losses of $5.4 million. Adjusted EBITDA reached $24.3 million, yielding an 8.2% margin. Total lives on the platform stood at 20.3 million. The company announced new partnerships, including AvMed's expansion into oncology services and Bright Healthcare's member increase for 2023. For Q2 2022, revenue guidance is set at $290.0 million to $305.0 million, while full-year revenue is projected between $1.16 billion and $1.21 billion.
Evolent Health (NYSE: EVH) will announce its first quarter 2022 operating results on May 4, 2022, after the market closes. A conference call will follow at 5:00 p.m. Eastern Time. Interested shareholders can access the live broadcast by calling 855.940.9467 or 412.317.6034 (international). An audio playback will be available for 30 days on the company's investor relations website. Evolent Health provides clinical and administrative solutions to enhance healthcare delivery, serving a national network of leading payers and providers.
New Century Health (NCH) reported that its partner, Cancer Care Specialists (CCSI) of Illinois, earned nearly $3.6 million from Medicare through the Oncology Care Model (OCM). This payment reflects CCSI's success in reducing care costs while achieving quality targets for Medicare beneficiaries. Per-beneficiary costs were 8% below Medicare's benchmark, with high scores in patient experience and lower hospital utilization rates. NCH aims to improve patient outcomes and reduce expenses through effective oncology management and a focus on value-based care.
Evolent Health, Inc. (NYSE: EVH) announced participation in two upcoming investor conferences. Chief Financial Officer John Johnson and Vice President of Investor Relations Seth Frank will present at the 42nd Annual Cowen Health Care Conference on March 7, 2022, at 9:10 a.m. ET, and at the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2022, at 9:00 a.m. ET. Live audio webcasts will be available on Evolent's investor relations website, with replays accessible shortly after the events.
Evolent Health (NYSE: EVH) reported Q4 and full-year financial results for 2021, showcasing GAAP revenue of $248.4 million, a slight increase of 0.7% year-over-year. In contrast, full-year revenue fell by 1.8% to $908.0 million. Notably, revenue excluding divested assets grew by 39.7% and 36.7% for Q4 and the full year, respectively. Despite a net loss of $(5.6) million in Q4 and $(37.6) million for 2021, Evolent achieved an Adjusted EBITDA of $24.3 million for Q4 and $66.3 million for the year. The company also announced new partnerships, enhancing its service delivery.
Summary not available.
Evolent Health (NYSE: EVH) has announced it will disclose its fourth quarter and full year 2021 operating results on February 23, 2022, after market close. Following the release, a conference call is scheduled at 5:00 p.m. Eastern Time. Participants can access the call by dialing 855.940.9467 or 412.317.6034 for international listeners, referencing the "Evolent Health call". An audio playback will be available on the company's investor relations website for one week after the event.
Evolent Health (NYSE: EVH) announced a partnership with PCG Consulting Group to establish a customer contact team in Cook County, Illinois, serving over 400,000 Medicaid members. This collaboration aims to enhance diversity and support minority communities. PCG, with 79% of its employees from underserved areas, provides crucial administrative and clinical services. The initiative aligns with Evolent's commitment to health equity and improving member experiences, particularly for Black and African American individuals in the area. The partnership is part of Evolent's broader strategy to promote diversity and community engagement.
Evolent Health (NYSE: EVH) will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 4:30 p.m. ET. CEO Seth Blackley and CFO John Johnson will participate in the virtual event. Investors can access a live audio-only webcast on Evolent's website, with a replay available shortly after the event. Evolent Health provides clinical and administrative solutions aimed at improving health care affordability and efficiency, and it serves a nationwide base of healthcare payers and providers.
Evolent Health, Inc. (NYSE: EVH) has appointed Seth R. Frank as the new Vice President of Investor Relations, effective immediately. Reporting to CFO John Johnson, Frank will enhance the company's investor relations strategy and engagement with the investment community. He brings extensive experience from roles at Hanger, Inc. and Allscripts, along with a background as an equity analyst. This strategic appointment aims to boost investor knowledge of Evolent's operations and reinforce its commitment to delivering long-term shareholder value.